Scarica l'app Stockscreener
1.30
13.91%
-0.21
Precedente Chiudi:
$1.51
Aprire:
$1.5
Volume 24 ore:
118.56K
Relative Volume:
0.14
Capitalizzazione di mercato:
$3.58M
Reddito:
$29.78M
Utile/perdita netta:
$-39.94M
Rapporto P/E:
-0.021
EPS:
-61.9139
Flusso di cassa netto:
$-16.12M
1 W Prestazione:
-19.25%
1M Prestazione:
-32.29%
6M Prestazione:
-94.23%
1 anno Prestazione:
-99.51%
Intervallo 1D:
$1.24
$1.50
Intervallo di 1 settimana:
$1.24
$1.61
Portata 52W:
$1.24
$581.85
22nd Century Group, Inc. Stock (XXII) Company Profile
Nome
22nd Century Group, Inc.
Settore
Industria
Telefono
716-270-1523
Indirizzo
8560 Main Street, Williamsville, NY
Confronta XXII con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
1.30 | 3.58M | 29.78M | -39.94M | -16.12M | -61.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.49 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
625.60 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
583.62 | 35.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.83 | 34.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
274.78 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-07-21 | Iniziato | Alliance Global Partners | Buy |
| 2022-06-15 | Iniziato | Craig Hallum | Buy |
| 2022-03-08 | Iniziato | ROTH Capital | Buy |
| 2021-07-23 | Iniziato | Cowen | Outperform |
| 2017-10-16 | Reiterato | Chardan Capital Markets | Buy |
| 2016-08-11 | Reiterato | Chardan Capital Markets | Buy |
Mostra tutto
22nd Century Group, Inc. Borsa (XXII) Ultime notizie
22nd Century Group, Inc. (NASDAQ:XXII) Q4 2024 Earnings Call Transcript - Insider Monkey
22nd Century reports $15.5 million loss for 2024; no net revenue from very-low-nicotine line - Winston-Salem Journal
22nd Century Group Inc (XXII) Q4 2024 Earnings Call Highlights: Navigating Challenges and ... - Yahoo
22nd Century outlines plans for VLN expansion and growth in 2025 - MSN
22nd Century Group Inc (XXII) Q4 2024 Earnings Call Highlights: Navigating Challenges and ... By GuruFocus - Investing.com Canada
22nd Century Group Inc (XXII) Q4 2024 Earnings Call Highlights: Navigating Challenges and Strategic Repositioning - GuruFocus.com
22nd Century Group Reports 2024 Financial Results - TipRanks
Earnings call transcript: 22nd Century Group Q4 2024 sees revenue drop - Investing.com Australia
Earnings call transcript: 22nd Century Group Q4 2024 sees revenue drop By Investing.com - Investing.com South Africa
22nd Century Group, Inc. SEC 10-K Report - TradingView
22nd Century Group reports annual financial results - Investing.com
22nd Century Group Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
22nd Century Group, Inc. Unveils 2025 Growth Strategy and Announces First VLN® Partner Brand with Smoker Friendly - Nasdaq
22nd Century Group reports annual financial results By Investing.com - Investing.com UK
22nd Century Group Earnings Reveal Major Transformation Plan as Losses Mount - StockTitan
22nd Century Group Earnings: CEO and CFO to Unveil Full Year Performance March 20 - StockTitan
22nd Century Group, Inc. to Host Webcast on March 20, 2025, for 2024 Financial Results and Future Plans - Nasdaq
22nd Century Group to Announce Fourth Quarter and Full Year 2024 Results on March 20, 2025 - The Manila Times
12 Cannabis Stocks to Buy Now in 2025 - MarketBeat
22nd Century Announces First Partner VLN Agreement, New VLN Availability with Smoker Friendly - GlobeNewswire
22nd Century Group expands VLN products with Smoker Friendly By Investing.com - Investing.com Australia
22nd Century Group expands VLN products with Smoker Friendly - Investing.com India
22nd Century Launches Reduced Nicotine Cigarettes Through Major Partnership - StockTitan
XXII stock plunges to 52-week low, touches $3.03 amid market rout - MSN
Weiss Ratings Reiterates “Sell (E)” Rating for 22nd Century Group (NASDAQ:XXII) - Defense World
XXII stock plunges to 52-week low of $1.72 amid market challenges - Investing.com Australia
22nd Century regains compliance with the Nasdaq - MSN
XXII stock plunges to 52-week low of $2.98 amid market challenges - Investing.com Nigeria
XXII stock plunges to 52-week low of $2.98 amid market challenges By Investing.com - Investing.com South Africa
22nd Century Group (NASDAQ:XXII) Given “Sell (E+)” Rating at Weiss Ratings - Defense World
Emerging Growth Research Releases New Initiation Report on the 22nd Century Group (XXII) - Newsfile
22nd Century : FDA Lead Scientist Discusses 22nd Century’s SPECTRUM® Research Cigarettes in Public Webcast - Marketscreener.com
22nd Century Group, Inc. (NASDAQ:XXII) Short Interest Down 63.8% in January - Defense World
XXII stock plunges to 52-week low, touches $3.03 amid market rout By Investing.com - Investing.com South Africa
22nd Century to Present at the Emerging Growth Conference on February 19, 2025 - Marketscreener.com
Exclusive: 22nd Century Group Unveils Strategic Vision at Emerging Growth ConferenceCEO Takes Center Stage - StockTitan
Weiss Ratings Reiterates Sell (E) Rating for 22nd Century Group (NASDAQ:XXII) - Defense World
22nd Century files to sell 104,124 shares of common stock for holders - MSN
22nd Century Group, Inc. Azioni (XXII) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):